United States (US) CIS Insulin Market (2025-2031) | Forecast, Competitive Landscape, Outlook, Industry, Growth, Analysis, Companies, Size & Revenue, Segmentation, Value, Share, Trends

Market Forecast By Application (Type I Diabetes, Type II Diabetes), By Product Type (Rapid Acting, Long Acting, Short Acting, Intermediate Acting, Premixed), By Source (Analog, Human Recombinant) And Competitive Landscape
Product Code: ETC9961516 Publication Date: Sep 2024 Updated Date: Nov 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sumit Sagar No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Cis Insulin Market Top 5 Importing Countries and Market Competition (HHI) Analysis

In 2024, the United States saw a significant decline in CIS insulin import shipments with a negative CAGR of -31.87% from 2020 to 2024 and a sharp growth rate decrease of -39.06% from 2023 to 2024. Despite the top exporting countries being Austria, Metropolitan France, Italy, Germany, and Brazil, the Herfindahl-Hirschman Index (HHI) indicated very low concentration in the market. This data suggests a challenging landscape for insulin imports into the US, signaling potential shifts in market dynamics or regulatory changes impacting the industry.

United States (US) Cis Insulin Market Top 5 Importing Countries and Market Competition (HHI) Analysis

Key Highlights of the Report:

  • United States (US) CIS Insulin Market Outlook
  • Market Size of United States (US) CIS Insulin Market, 2024
  • Forecast of United States (US) CIS Insulin Market, 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Revenues & Volume for the Period 2021- 2031
  • United States (US) CIS Insulin Market Trend Evolution
  • United States (US) CIS Insulin Market Drivers and Challenges
  • United States (US) CIS Insulin Price Trends
  • United States (US) CIS Insulin Porter's Five Forces
  • United States (US) CIS Insulin Industry Life Cycle
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Application for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Type I Diabetes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Type II Diabetes for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Product Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Rapid Acting for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Long Acting for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Short Acting for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Intermediate Acting for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Premixed for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Source for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Analog for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) CIS Insulin Market Revenues & Volume By Human Recombinant for the Period 2021- 2031
  • United States (US) CIS Insulin Import Export Trade Statistics
  • Market Opportunity Assessment By Application
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Source
  • United States (US) CIS Insulin Top Companies Market Share
  • United States (US) CIS Insulin Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) CIS Insulin Company Profiles
  • United States (US) CIS Insulin Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) CIS Insulin Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) CIS Insulin Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) CIS Insulin Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) CIS Insulin Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) CIS Insulin Market - Industry Life Cycle

3.4 United States (US) CIS Insulin Market - Porter's Five Forces

3.5 United States (US) CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F

3.6 United States (US) CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 United States (US) CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F

4 United States (US) CIS Insulin Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in the US

4.2.2 Technological advancements in insulin delivery systems

4.2.3 Growing awareness about the benefits of early insulin therapy

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for insulin products

4.3.2 High cost associated with insulin therapy

4.3.3 Potential side effects and risks associated with insulin use

5 United States (US) CIS Insulin Market Trends

6 United States (US) CIS Insulin Market, By Types

6.1 United States (US) CIS Insulin Market, By Application

6.1.1 Overview and Analysis

6.1.2 United States (US) CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F

6.1.3 United States (US) CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F

6.1.4 United States (US) CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F

6.2 United States (US) CIS Insulin Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 United States (US) CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F

6.2.3 United States (US) CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F

6.2.4 United States (US) CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F

6.2.5 United States (US) CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F

6.2.6 United States (US) CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F

6.3 United States (US) CIS Insulin Market, By Source

6.3.1 Overview and Analysis

6.3.2 United States (US) CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F

6.3.3 United States (US) CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F

7 United States (US) CIS Insulin Market Import-Export Trade Statistics

7.1 United States (US) CIS Insulin Market Export to Major Countries

7.2 United States (US) CIS Insulin Market Imports from Major Countries

8 United States (US) CIS Insulin Market Key Performance Indicators

8.1 Average age of diabetes diagnosis in the US

8.2 Adoption rate of new insulin delivery technologies

8.3 Number of diabetes education programs conducted annually

8.4 Percentage of diabetic patients with controlled blood sugar levels

8.5 Rate of hospital admissions due to diabetes-related complications

9 United States (US) CIS Insulin Market - Opportunity Assessment

9.1 United States (US) CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F

9.2 United States (US) CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 United States (US) CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F

10 United States (US) CIS Insulin Market - Competitive Landscape

10.1 United States (US) CIS Insulin Market Revenue Share, By Companies, 2024

10.2 United States (US) CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All